Publication | Open Access

Abatacept treatment for patients with early active primary Sjögren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study)

Rheumatoid DisorderRheumatologyAutoimmune DiseaseAllergySjögren’s SyndromeAbatacept TreatmentClinical TrialsAsap-iii StudySclerodermaMedicineRheumatoid Arthritis